LABD vs. KORU
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and KORU (Direxion Daily South Korea Bull 3X Shares) are both Leveraged Equities funds from Direxion - LABD tracks the S&P Biotechnology Select Industry Index (-300%) while KORU tracks the MSCI Korea 25-50 Index. Both are passively managed. Over the past 10 years, LABD returned -59.30%/yr vs 15.15%/yr for KORU. At a correlation of -0.38, they often move in opposite directions. LABD charges 1.06%/yr vs 1.29%/yr for KORU.
Performance
LABD vs. KORU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -56.07% return, which is significantly lower than KORU's 308.29% return. Over the past 10 years, LABD has underperformed KORU with an annualized return of -59.30%, while KORU has yielded a comparatively higher 15.15% annualized return.
LABD
- 1D
- -5.68%
- 1M
- -35.65%
- YTD
- -56.07%
- 6M
- -51.34%
- 1Y
- -86.96%
- 3Y*
- -57.71%
- 5Y*
- -43.47%
- 10Y*
- -59.30%
KORU
- 1D
- 5.90%
- 1M
- -5.01%
- YTD
- 308.29%
- 6M
- 341.55%
- 1Y
- 789.62%
- 3Y*
- 104.57%
- 5Y*
- 12.17%
- 10Y*
- 15.15%
LABD vs. KORU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -56.07% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -70.80% | -6.26% | -75.67% |
KORU Direxion Daily South Korea Bull 3X Shares | 308.29% | 432.73% | -62.18% | 28.61% | -70.16% | -33.86% | 48.78% | 5.47% | -59.89% | 167.08% |
Correlation
The correlation between LABD and KORU is -0.35, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.35 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.35 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.39 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.38 |
Correlation (All Time) Calculated using the full available price history since May 28, 2015 | -0.38 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. KORU — Risk / Return Rank
LABD
KORU
LABD vs. KORU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily South Korea Bull 3X Shares (KORU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LABD | KORU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -6.66 | ||
| Sortino ratioReturn per unit of downside risk | -6.19 | ||
| Omega ratioGain probability vs. loss probability | 0.70 | 1.51 | -0.81 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | 12.99 | -13.98 |
| Martin ratioReturn relative to average drawdown | -1.37 | 37.77 | -39.14 |
Loading charts...
Drawdowns
LABD vs. KORU - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, roughly equal to the maximum KORU drawdown of -95.79%. Use the drawdown chart below to compare losses from any high point for LABD and KORU.
Loading charts...
Drawdown Indicators
| LABD | KORU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -95.79% | -4.20% |
Max Drawdown (1Y)Largest decline over 1 year | -87.41% | -61.39% | -26.02% |
Max Drawdown (3Y)Largest decline over 3 years | -96.58% | -73.34% | -23.24% |
Max Drawdown (5Y)Largest decline over 5 years | -98.72% | -93.34% | -5.38% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | -95.79% | -4.20% |
Current DrawdownCurrent decline from peak | -99.99% | -41.40% | -58.59% |
Average DrawdownAverage peak-to-trough decline | -90.99% | -57.41% | -33.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 63.63% | 21.07% | +42.56% |
Volatility
LABD vs. KORU - Volatility Comparison
The current volatility for Direxion Daily S&P Biotech Bear 3x Shares (LABD) is 29.86%, while Direxion Daily South Korea Bull 3X Shares (KORU) has a volatility of 92.24%. This indicates that LABD experiences smaller price fluctuations and is considered to be less risky than KORU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | KORU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.86% | 92.24% | -62.38% |
Volatility (6M)Calculated over the trailing 6-month period | 64.89% | 138.68% | -73.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.92% | 144.21% | -65.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.65% | 91.42% | +5.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.96% | 83.04% | +12.92% |
LABD vs. KORU - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is lower than KORU's 1.29% expense ratio.
Dividends
LABD vs. KORU - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 7.15%, more than KORU's 0.21% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
KORU Direxion Daily South Korea Bull 3X Shares | 0.21% | 0.89% | 4.10% | 2.55% | 0.48% | 0.76% | 0.01% | 0.93% | 1.40% | 3.59% |
LABD Direxion Daily S&P Biotech Bear 3x Shares | 7.15% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% | 0.00% |
Frequently Asked Questions
LABD and KORU have a correlation of -0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KORU has higher volatility (92.24%) compared to LABD (29.86%). In terms of maximum drawdown, LABD dropped -99.99% vs KORU's -95.79%.
On 10-year performance, KORU leads with 15.15% vs -59.30% for LABD. On fees, LABD is cheaper at 1.06% per year. On volatility, LABD has been the lower-risk option at 29.86%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, KORU has performed better with a 15.15% return vs -59.30%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
LABD is cheaper with a 1.06% expense ratio, compared with 1.29% for KORU.
LABD has the higher dividend yield at 7.15%, compared with 0.21% for KORU.
LABD tracks S&P Biotechnology Select Industry Index (-300%), while KORU tracks MSCI Korea 25-50 Index. Their fees differ too: 1.06% for LABD and 1.29% for KORU.
KORU currently has the higher Sharpe Ratio (5.55 vs -1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and KORU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer